NCT03412643 2023-03-06
FB-12
NSABP Foundation Inc
Phase 2 Unknown
Clinical Trials
4 trialsNCT03457896 2022-03-31
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
NSABP Foundation Inc
Phase 2 Unknown
NCT00486668 2016-06-06
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
NSABP Foundation Inc
Phase 3 Unknown
NCT00518583 2010-01-15
Phase II Study in Patients With Operable Breast Cancer
Aptium Oncology Research Network
Phase 2 Unknown